Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Headache|April 18, 2015
Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) StudyDawn C Buse, Daniel Serrano, Michael L Reed, et al.
Headache|November 24, 2011
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodyniaStewart J Tepper, Shashidhar H Kori, Scott W Borland, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Mayo Clinic Proceedings|February 9, 2007
Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migrainePaul Winner, Roger K Cady, Gary E Ruoff, et al.
Headache|July 2, 2013
Effects of switching acute treatment on disability in migraine patients using triptansDaniel Serrano, Dawn C Buse, Shashi H Kori, et al.
Cephalalgia : an International Journal of Headache|August 1, 2014
Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous veinSieneke Labruijere, Kayi Y Chan, René de Vries, et al.
Annals of Neurology|March 5, 2009
Medullary pain facilitating neurons mediate allodynia in headache-related painRebecca M Edelmayer, Todd W Vanderah, Lisa Majuta, et al.
Pageof 3